Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease

Journal of the Chinese Medical Association

Volumn 77, Issue 7, 2014, Pages 354-359

  Chang, Shen Shong ^a,b   Hu, Hsiao Yun ^a,b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chronic kidney disease; End stage renal disease; H. pylori; Lower; Peptic ulcers

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; RETROSPECTIVE STUDY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COMPLICATION; HELICOBACTER INFECTIONS; MIDDLE AGED; REGRESSION ANALYSIS; TAIWAN;

ADULT; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIC ULCER; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84904045207     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2014.04.004     Document Type: Article

References (26)

1. Tseng G.Y., Lin H.J., Fang C.T., Yang H.B., Tseng G.C., Wang P.C., et al. Recurrence of peptic ulcer in uremic and non-uremic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther 2007, 26:925-933.
2. Milito G., Taccone-Gallucci M., Brancaleone C., Nardi F., Filingeri V., Cesca D., et al. Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol 1983, 78:328-331.
3. Kang J.Y., Ho K.Y., Yeoh K.G., Guan R., Wee A., Lee E., et al. Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol 1999, 14:771-778.
4. Gasbarrini G., Pretolani S., Bonvicini F., Gatto M.R., Tonelli E., Megraud F., et al. A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut 1995, 36:838-844.
5. Suerbaum S., Michetti P. Helicobacter pylori infection. N Engl J Med 2002, 347:1175-1186.
6. Talley N.J., Fock K.M., Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008, 103:510-514.
7. Gur G., Boyacioglu S., Gul C., Turan M., Gursoy M., Baysal C., et al. Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients. Nephrol Dial Transplant 1999, 14:2688-2691.
8. Ala-Kaila K. Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol 1987, 22:372-376.
9. Nakajima F., Sakaguchi M., Amemoto K., Oka H., Kubo M., Shibahara N., et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol 2002, 2:468-472.
10. Amieva M.R., El-Omar E.M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008, 134:306-323.
11. Wu M.S., Chen C.J., Lin J.T. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:1878-1882.
12. Sotoudehmanesh R., Ali Asgari A., Ansari R., Nouraie M. Endoscopic findings in end-stage renal disease. Endoscopy 2003, 35:502-505.
13. Loffeld R.J., Peltenburg H.G., Oever H., Stobberingh E. Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent haemodialysis. Nephron 1991, 59:250-253.
14. Davenport A., Shallcross T.M., Crabtree J.E., Davison A.M., Will E.J., Heatley R.V. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron 1991, 59:597-601.
15. Luzza F., Imeneo M., Maletta M., Mantelli I., Tancre D., Merando G., et al. Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology. Nephrol Dial Transplant 1996, 11:120-124.
16. Jaspersen D., Fassbinder W., Heinkele P., Kronsbein H., Schorr W., Raschka C., et al. Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J Gastroenterol 1995, 30:585-588.
17. Khedmat H., Ahmadzad-Asl M., Amini M., Lessan-Pezeshki M., Einollahi B., Pourfarziani V., et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007, 39:1003-1007.
18. Sugimoto M., Sakai K., Kita M., Imanishi J., Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009, 75:96-103.
19. Hsiao F.Y., Tsai Y.W., Wen Y.W., Kuo K.N., Tsai C.R., Huang W.F. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event. Pharmacotherapy 2011, 31:239-247.
20. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
21. Liou J.M., Chen C.C., Chen M.J., Chen C.C., Chang C.Y., Fang Y.J., et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomized trial. Lancet 2013, 381:205-213.
22. Cameron E.A., Bell G.D., Baldwin L., Powell K.U., Williams S.G. Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2006, 23:1355-1358.
23. Xia H.H., Phung N., Kalantar J.S., Talley N.J. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust 2000, 173:515-519.
24. Shahin W.A., Abdel-Baset E.Z., Nassar A.K., Atta M.M., Kabil S.M., Murray J.A. Low incidence of Helicobacter pylori infection in patients with duodenal ulcer and chronic liver disease. Scand J Gastroenterol 2001, 36:479-484.
25. Chang S.S., Hu H.Y. Helicobacter pylori is not the predominant etiology for liver cirrhosis patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2013, 25:159-165.
26. Hopkins R.J., Girardi L.S., Turney E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996, 110:1244-1252.